VivoSim Labs, Inc (VIVS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

VivoSim Labs, Inc (VIVS) is down 30.4% since the beginning of the year. At $1 per share, VIVS is trading 76.2% below its 52-week high of $5. Investors who bought $1,000 worth of VIVS shares 5 years ago would now be looking at an investment worth $12.

VivoSim Labs, Inc (VIVS) has returned -30.39% so far this year and -29.01% over the past 12 months. Over the last ten years, VIVS has returned -46.67% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Feb 14, 2012, VIVS's average daily return is +0.06%, while the average monthly return is -0.64%.

Historically, 41% of months were positive and 59% were negative. The best month was May 2012 with a return of +95.2%, while the worst month was Mar 2025 at -71.3%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, VIVS closed higher 44% of trading days. The best single day was Feb 25, 2025 with a return of +244.2%, while the worst single day was Jun 27, 2012 at -58.6%.

VivoSim Labs, Inc has an annualized alpha of 2.65%, beta of 0.99, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since February 15, 2012.

• This stock participated in 217.50% of S&P 500 Index downside but only 14.59% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

VIVS ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for VivoSim Labs, Inc (VIVS) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the VivoSim Labs, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the VivoSim Labs, Inc was 99.96%, occurring on Jun 3, 2026. The portfolio has not yet recovered.

The current VivoSim Labs, Inc drawdown is 99.96%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of VivoSim Labs, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how VivoSim Labs, Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.